- Current treatment options for pediatric leukemia and lymphoma
- Follow-up care after treatment ends
- Clinical trials and emerging therapies for treatment resistant or relapsed childhood blood cancers
- Quality-of-life issues for patients and caregivers
Sima Jeha, M.D.
Director, Leukemia/Lymphoma Developmental Therapeutics
Department of Oncology
St. Jude Children's Research Hospital